About our data

Educational research product. Seed corpus: 46 companies, 59 catalysts.

What is NOT verified yet: cash balances, monthly burn, Survive-to-Event, race-progress bars, editorial theses, and most catalyst dates were curated for product scaffolding. Some NCT↔program links may be wrong until reconciled against ClinicalTrials.gov. Do not treat them as audited facts.

What is grounded

Public company tickers and known commercial franchises (e.g. Tagrisso, Keytruda, Carvykti) as starting points.
ClinicalTrials.gov enrichment when pnpm run fin-bio:sync succeeds (title, status, phase).
Date confidence tags: only trust Confirmed after you open the source link.

Sources

ClinicalTrials.gov API v2 — trial status via pnpm run fin-bio:sync.
openFDA — Drugs@FDA context when available.
SEC / curated cash — educational cash & burn with as-of dates.
Company IR — PDUFA and guided windows when disclosed.

Survive-to-Event

Days of cash ≈ (cash ÷ monthly burn) × 30.4, compared to days until the next gate. Transparent arithmetic — not a probability of approval.